All sponsors

Ono Pharmaceutical Co., Ltd. $4528.T

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS20
PHASE 3 / 2-38
RECRUITING11
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO15%

Delay Index: of 13 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Ono Pharmaceutical Co., Ltd. on the live radar map → 📅 $4528.T readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ONO-2808
NCT05923866
P2Active, not recruitingMultiple System Atrophy (MSA)922025-09-15
ONO-4578
NCT06256328
P2Active, not recruitingGastric Cancer2262025-10-09 (-2 mo)
ONO-4538
NCT05144854
P3Active, not recruitingGastric Cancer6262025-10-20 (-15 mo)
Tirabrutinib
NCT04947319
P2Active, not recruitingRefractory Primary Central Nervous System Lymphoma; Primary CNS Lymphoma1192026-01-27 (+20 mo)
ONO-2020
NCT06803823
P2RecruitingAgitation Associated With Alzheimer's Disease Dementia902026-12-31
Cenobamate
NCT06579573
P3RecruitingEpilepsy, Generalized152027-01-31
Cenobamate
NCT06590896
P2RecruitingEpilepsies, Partial1002027-01-31
ONO-4059
NCT06696716
P3Active, not recruitingPemphigus; Steroid-resistant Pemphigus342027-09-30
IGNITE
NCT07104032
P3RecruitingRelapsed/Refractory Primary Central Nervous System Lymphoma1322027-12
ONO-4538
NCT04566380
P2RecruitingPan-tumor702027-12-31 (+27 mo)
ONO-4578
NCT06948448
P2RecruitingColorectal Cancer1442028-02-15
Cenobamate (tablet) for 12 to < 18 year olds
NCT07594158
P3RecruitingPartial Epilepsy202028-03-30
DCC-3014
NCT07832747
P2Not yet recruitingTenosynovial Giant Cell Tumor182028-08-31
INTREPID
NCT07429266
P3RecruitingPolycythemia Vera2502028-09
ONO-4538
NCT06622941
P2RecruitingRhabdoid Tumor232029-01-31
ONO-4915
NCT07823790
P2Not yet recruitingSjogren's Disease602029-02
ONO-4538
NCT06936943
P2RecruitingRichter's Transformation142029-07-31
ONO-2808
NCT07825402
P3Not yet recruitingMultiple System Atrophy, Parkinson Variant4862029-10
ONO-4538HSC
NCT07734116
P1/2RecruitingPediatric Malignant Solid Tumor and Epithelioid Sarcoma502029-11-30
ONO-4578
NCT07818070
P3Not yet recruitingGastric Cancer; Esophagogastric Junction Cancer6002031-01